Attached files

file filename
8-K - FORM 8-K - GENTHERM Incd253421d8k.htm

Exhibit 99.1

LOGO

NEWS RELEASE for November 8, 2011 at 6:00 AM ET

 

Contact:   Allen & Caron Inc
  Jill Bertotti (investors)
  jill@allencaron.com
  Len Hall (media)
  len@allencaron.com
  (949) 474-4300

AMERIGON REPORTS 2011 THIRD QUARTER, NINE-MONTH RESULTS

First Quarter to Include Full Quarter of Operating Results of W.E.T.

NORTHVILLE, MI (November 8, 2011) . . . Amerigon Incorporated (NASDAQ-GS: ARGN), a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications, today announced its financial results for the third quarter and nine months ended September 30, 2011. On May 16, 2011, Amerigon closed the previously announced acquisition of controlling interest of W.E.T. Automotive Systems AG, a publicly-traded German automotive thermal control and electronic components company. As a result, the 2011 third quarter includes a full quarter of operating results of W.E.T. for the first time and the nine-month period includes four and one-half months of W.E.T. operations. Also, included in the 2011 results are fees and expenses associated with the W.E.T. acquisition, which are detailed in the Acquisition Transaction Expenses, W.E.T. Purchase Accounting Impacts and Other Effects table accompanying the release.

“We continue to make important progress in the transformation of Amerigon into a much larger, more capable global company with a significant presence in North America, Europe and Asia,” said President and CEO Daniel R. Coker. “We remain optimistic about our ongoing acquisition of W.E.T. Automotive Systems, which we believe will enhance our capabilities in product development and thermal management innovation, broaden our global footprint, provide manufacturing capability and make us a much more competitive supplier in the worldwide automotive industry.”

Coker added that Amerigon’s newest products, including the heated and cooled cupholder for the automotive market, and the heated and cooled luxury mattress, have both generated growing revenue streams. Also, Amerigon’s new thermoelectric generator, or TEG, that converts waste vehicle exhaust heat into electricity, developed with the U.S. Department of Energy, BMW and Ford, among others, is currently being tested on BMW and Ford vehicles, Coker noted.

“Our innovative TEG system may become a very important advancement in automotive engineering,” Coker said. “It not only provides modern vehicles a supplemental source of electricity, but it also offers benefits in fuel economy and a reduction in toxic emissions, including carbon dioxide gas. We, and all our partners, are very excited about the potential of this unique technology.”


Third Quarter Summary

Product revenues for this year’s third quarter increased to $125.6 million from $30.5 million in the prior year period. The increase in revenues primarily reflects additional W.E.T. revenue of $95.1 million. The W.E.T. revenues include the effects of the first historical Amerigon vehicle program to be sourced in a W.E.T. facility totaling $4.4 million.

The 2011 third quarter showed a loss attributable to common shareholders of $1.6 million, or $0.07 loss per share, which reflected the significant impact of acquisition-related write-offs and one-time charges related to the acquisition and related financing totaling $3.3 million net of tax benefit, or $0.14 per basic and diluted share. These effects detailed in the attached table, importantly include amortization of the portion of the acquisition price assigned to intangibles (which totaled $126.8 million), write-off of the acquired inventory marked up to fair value, and the write-off of acquisition costs and debt retirement expenses. Excluding these non-cash charges, Amerigon would have earned $1.6 million, or $0.07 per basic and diluted share.

Also in this year’s third quarter, Amerigon satisfied its obligation to pay accrued dividends of $2.4 million of the Series C Preferred Stock issued in connection with the W.E.T. acquisition by issuing common shares to the holders of Series C Preferred Stock in lieu of cash dividends. As planned in the Company’s financing package, the dividend reduced third quarter net income attributable to common shareholders by $2.8 million, or $0.12 per basic and diluted share. The preferred dividend will decrease to $1.2 million by the fourth quarter of 2012, and will be totally eliminated by the fourth quarter of 2013, as the Series C Preferred Stock is redeemed over the next eight quarters. Amerigon redeemed the first installment of Series C Preferred Stock on September 1, 2011. That installment, together with the shares delivered in lieu of a cash dividend, totaled approximately 866,000 common shares. Amerigon has delivered notice to the holders of the Series C Preferred Stock that it will redeem the second dividend and redemption installment on December 1, 2011 in cash totaling $9.0 million as Amerigon’s cash flows are adequate to do so.

Gross margin as a percentage of revenue for the 2011 third quarter was 25 percent, compared with 29 percent in the third quarter of 2010 (for Amerigon alone). The decrease primarily reflects W.E.T.’s lower gross margin on sales (24 percent), and for Amerigon, higher material costs driven by the strong Japanese Yen and an unfavorable mix of products sold. The W.E.T. gross margin is significantly impacted by acquisition accounting. In the near term, W.E.T’s inventory is required to be marked up to fair value, for an effect of $374,000, or 0.4 percent. In addition, the write-off of the purchase price allocated to customer relationships amounted to $2.1 million in the third quarter, which reduced W.E.T.’s gross margin by an additional 1.7 percent.

Adjusted EBITDA (which is described in the tables that follow) for the 2011 third quarter was $15.5 million compared with Adjusted EBITDA of $4.4 million for the prior year period.

The historical Amerigon financial results and Adjusted EBITDA for this year’s third quarter, which are non-GAAP measures, are provided to help shareholders understand Amerigon’s results of operations due to the acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Amerigon’s reported results prepared in accordance with GAAP.

Year-to-Date Financial Highlights

The Company reported a net loss attributable to common shareholders for this year’s first nine months of $3.9 million, or $0.17 loss per basic and diluted share. Included in the 2011 nine-month results are fees and expenses associated with the W.E.T. acquisition and non-cash purchase accounting amortization and adjustments for inventory revaluation, which are detailed in the Acquisition


Transaction Expenses, W.E.T. Purchase Accounting Impacts and Other Effects table accompanying the release. In total, these have decreased the Company’s net income attributable to common shareholders for the first nine months of 2011 by $11.0 million net of tax benefit, or $0.49 per basic and $0.48 per diluted share. Adjusting for these, Amerigon would have reported net income attributable to common shareholders of $7.1 million, or $0.32 per basic and $0.31 per diluted share. The nine-month results also include the convertible preferred stock dividends of $5.7 million, which reduced net income attributable to common shareholders by $0.26 per basic and $0.25 per diluted share. Adjusting for all of these effects, Amerigon would have reported net income attributable to common shareholders of $12.9 million, or $0.58 per basic and $0.55 per diluted share as compared with net income attributable to common shareholders in the prior year period of $6.6 million, or $0.31 per basic and $0.30 per diluted share.

For the first nine months of 2011, product revenues increased to $238.6 million, up 186 percent from $83.5 million in the prior year period. This includes operating results from W.E.T. beginning May 16, 2011, and non-cash amortization of W.E.T.’s customer relationships. Gross margin as a percentage of revenue for this year’s first nine months was 26 percent compared with 29 percent in the first nine months of 2010, largely reflecting lower margins on W.E.T. revenue, non-cash purchase accounting impacts, higher material costs for Amerigon, including the effects of a stronger Japanese Yen, and unfavorable product mix. Non-cash purchase accounting impacts totaling $6.6 million reduced the gross margin percent by 4.0 percent.

Adjusted EBITDA for the first nine months of 2011 was $35.5 million compared to Adjusted EBITDA of $10.9 million for the prior year period.

The Company’s balance sheet as of September 30, 2011, had total cash and cash equivalents of $17.1 million, total assets of $402.8 million, and shareholders’ equity of $110.7 million. Total debt was $81.3 million and the book value of the unredeemed Series C Convertible Preferred Stock was $56.6 million as of September 30, 2011.

Interest Expense and Revaluation of Derivatives

Interest expense for the 2011 third quarter and first nine-months was $1.2 million and $2.5 million, respectively, compared with $9,000 in interest income for both prior year periods. A portion of interest expense for 2011 resulted from debt financing used to finance a portion of the W.E.T. acquisition. Approximately $621,000 in interest expense was related to the debt of W.E.T.

For this year’s third quarter and first nine months, the Company recorded losses related to the revaluation of derivative financial instruments totaling $4.3 million and $5.6 million, respectively. The nine-month amount included losses from the derivatives of W.E.T. totaling $8.2 million offset partially by $2.6 million of gains from revaluation of derivatives for Amerigon. W.E.T.’s derivative losses stem from its Cash Related Swap (CRS) contract and portfolio of currency derivative instruments. The Amerigon revaluation gain resulted from two derivatives embedded in its Series C Convertible Preferred Stock. These two derivatives, which were valued as liabilities totaling $2.6 million when the Series C Convertible Preferred Stock was issued, related to terms in which the Series C Preferred Stockholders would have received a redemption premium and certain warrants if the W.E.T. acquisition had not been completed. The carrying value of these derivatives was adjusted to zero upon consummation of the W.E.T. acquisition.

The Company recorded an income tax expense of $4.1 million representing an effective tax rate of 71 percent. This rate was higher than the U.S. statutory rate of 35 percent due to expenses that are not deductible for income tax purposes including a significant portion of the acquisition transaction


expenses, withholding and other local jurisdiction taxes for W.E.T. incurred during the period and the effect of having higher income in foreign jurisdictions with high tax rates as compared to losses in foreign jurisdictions having lower tax rates.

Research and Development, Selling, General and Administrative Expenses

The 2011 third quarter and nine-month results include a year-over-year increase in net research and development expenses of $9.0 million and $11.4 million, respectively. The increase for the 2011 third quarter was primarily due to net research and development expenses from W.E.T. totaling $8.9 million. The remaining increase represents increases in sponsored research, partially offset by the timing of receipt of research and development reimbursements. For the 2011 nine-month period, the increase was primarily due to the net research and development expenses from W.E.T. totaling $11.1 million and a year-over-year increase in net research and development expenses of Amerigon of $321,000, primarily due to the advanced thermoelectric materials program at the Company’s wholly-owned ZT Plus subsidiary.

Selling, general and administrative expenses for the 2011 third quarter and nine-month period increased $11.0 million and $18.6 million, respectively. The increase for this year’s third quarter and first nine months is primarily due to the selling, general and administrative expenses of W.E.T. totaling $9.8 million and $15.9 million, respectively, the opening of offices in Germany and China, certain costs related to integration activities of the W.E.T. acquisition and bad debt reserves on certain existing accounts receivable. For the 2011 third quarter and first nine months, the selling, general and administrative expenses of W.E.T. include amortization of the fair value of W.E.T.’s customer order backlog totaling $1.5 million and $3.1 million, respectively.

Guidance

The Company expects product revenues in the 2011 fourth quarter to be slightly lower compared with the 2011 third quarter due to the historically lower fourth quarter industry volumes in North America and Europe. There is some potential weakness in the North American and European markets, but sales for both companies are running ahead of business plan projections.

Conference Call

As previously announced, Amerigon is conducting a conference call today to be broadcast live over the Internet at 11:30 AM Eastern Time to review these financial results. The dial-in number for the call is 1-888-846-5003. The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Amerigon’s website at www.amerigon.com.

Note Regarding Use of Non-GAAP Financial Measures

Certain of the information set forth herein, including Adjusted EBITDA and historical Amerigon financial results, may be considered non-GAAP financial measures. Amerigon believes this information is useful to investors because it provides a basis for measuring Amerigon’s available capital resources, the operating performance of Amerigon’s business and Amerigon’s cash flow that would normally be included in the most directly comparable measures calculated and presented in accordance with Generally Accepted Accounting Principles. Amerigon’s management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measures in evaluating Amerigon’s operating performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP. Reconciliation between net income and EBITDA is provided in the financial tables at the end of this news release.


About Amerigon

Amerigon (NASDAQ-GS:ARGN) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products based on Amerigon and W.E.T. technologies include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, heated seat and steering wheel systems, cable systems and other electronic devices. Its advanced technology team is developing more efficient materials for thermoelectrics and systems for waste heat recovery and electrical power generation for the automotive market that also have far-reaching applications for consumer products as well as industrial and technology markets. Amerigon has approximately $500 million in annual revenues and 5,000 employees in facilities in the U.S., Germany, Mexico, China, Canada, Japan, England, Korea and the Ukraine. For more information, go to www.amerigon.com.

Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company’s actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to Amerigon’s Securities and Exchange Commission filings and reports, including, but not limited to, its Form 10-Q for the period ended September 30, 2011, and its Form 10-K for the year ended December 31, 2010.

TABLES FOLLOW


AMERIGON INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011     2010  

Product revenues

   $ 125,639      $ 30,486      $ 238,572      $ 83,486   

Cost of sales

     94,795        21,681        177,671        59,334   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     30,844        8,805        60,901        24,152   

Operating expenses:

        

Research and development

     11,520        2,789        18,921        9,158   

Research and development reimbursements

     (235     (490     (581     (2,193
  

 

 

   

 

 

   

 

 

   

 

 

 

Net research and development expenses

     11,285        2,299        18,340        6,965   

Acquisition transaction expenses

     200        —          5,380        —     

Selling, general and administrative

     13,545        2,498        26,092        7,449   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     25,030        4,797        49,812        14,414   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     5,814        4,008        11,089        9,738   

Interest income (expense)

     (1,213     9        (2,450     9   

Debt retirement expense

     (3     —          (970     —     

Revaluation of derivatives

     (4,305     —          (5,574     —     

Foreign currency gain

     2,006        —          3,412        —     

Loss from equity investment

     —          —          —          (22

Other income

     193        37        281        109   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings before income tax

     2,492        4,054        5,788        9,834   

Income tax (expense) benefit

     (973     1,492        (4,117     3,612   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     1,519        2,562        1,671        6,222   

Gain (loss) attributable to non-controlling interest

     (348     129        175        426   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Amerigon, Inc.

     1,171        2,691        1,846        6,648   

Convertible preferred stock dividends

     (2,815     —          (5,738     —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to common shareholders

   $ (1,644   $ 2,691      $ (3,892   $ 6,648   
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings (loss) per share

   $ (0.07   $ 0.12      $ (0.17   $ 0.31   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings (loss) per share

   $ (0.07   $ 0.12      $ (0.17   $ 0.30   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares – basic

     22,753        21,713        22,351        21,623   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares – diluted

     22,753        22,488        22,351        22,355   
  

 

 

   

 

 

   

 

 

   

 

 

 

MORE-MORE-MORE


AMERIGON INCORPORATED

RESULTS EXCLUDING W.E.T.

The following tables present select operations data for the periods as reported, amounts for W.E.T. operations and amounts for Amerigon less the W.E.T. amounts representing the historical portion of Amerigon. These Historical Amerigon financial results for the three- and nine-month periods ended September 30, 2011, which are non-GAAP measures, are provided to help shareholders understand Amerigon’s results of operations due to the acquisition of W.E.T. These non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Amerigon’s reported results prepared in accordance with GAAP.

 

     Three month period ended September 30,  
     2011     2010  
     As Reported     Less: W.E.T.     Historical Amerigon  
     (In Thousands)  

Product revenues

   $ 125,639      $ 95,122      $ 30,517      $ 30,486   

Cost of sales

     94,795        72,584        22,211        21,681   

Gross margin

     30,844        22,538        8,306        8,805   

Gross margin percent

     24.5     23.7 %(2)      27.2     28.9

Operating expenses:

        

Net research and development expenses

     11,285        8,949        2,336        2,299   

Acquisition transaction expenses

     200        6        194        —     

Selling, general and administrative expenses

     13,545        9,838        3,707        2,498   

Operating income

     5,814        3,745        2,069        4,008   

Earnings (loss) before income tax

     2,492        1,030        1,462        4,054   
     Nine month period ended September 30,  
     2011     2010  
     As Reported     Less:  W.E.T.(1)     Historical Amerigon  
     (In Thousands)  

Product revenues

   $ 238,572      $ 140,300      $ 98,272      $ 83,486   

Cost of sales

     177,671        107,042        70,629        59,334   

Gross margin

     60,901        33,258        27,643        24,152   

Gross margin percent

     25.5     23.7 %(2)      28.1     28.6

Operating expenses:

        

Net research and development expenses

     18,340        11,054        7,286        6,965   

Acquisition transaction expenses

     5,380        713        4,667        —     

Selling, general and administrative expenses

     26,092        15,912        10,180        7,449   

Operating income

     11,089        5,579        5,510        9,738   

Earnings (loss) before income tax

     5,788        (353     6,141        9,834   

 

(1) Only represents W.E.T.’s results for the period from May 16, 2011, the acquisition date, through September 30, 2011.
(2) Includes inventory re-evaluation and customer relationship amortization expense which reduced W.E.T.’s gross margin percent for the three and nine month periods by 2.1 percent and 2.9 percent, respectively.

MORE-MORE-MORE


Reconciliation of Adjusted EBITDA to Net Income

(Unaudited, in thousands)

 

     Three Months  Ended
September 30,
    Nine Months Ended
September 30,
 
     2011     2010     2011      2010  

Net Income

   $ 1,519      $ 2,562      $ 1,671       $ 6,222   

Add Back:

         

Income tax expense

     973        1,491        4,117         3,611   

Interest expense (income)

     1,213        (9     2,450         (9

Depreciation and amortization

     9,075        337        14,955         1,006   

Adjustments:

         

Acquisition transaction expense

     200        —          5,380         —     

Debt retirement expenses

     3        —          970         —     

Unrealized currency (gain) loss

     (353     12        1,855         41   

Unrealized revaluation of derivatives

     2,872        —          4,141         —     
  

 

 

   

 

 

   

 

 

    

 

 

 

Adjusted EBITDA

   $ 15,502      $ 4,393      $ 35,539       $ 10,871   
  

 

 

   

 

 

   

 

 

    

 

 

 

Use of Non-GAAP Financial Measures

In evaluating its business, Amerigon considers and uses Adjusted EBITDA as a supplemental measure of its operating performance. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, and deferred financing cost amortization, less transaction expenses, debt retirement expenses, unrealized currency (gain) loss and unrealized revaluation of derivatives. Management believes that Adjusted EBITDA is a meaningful measure of liquidity and the Company’s ability to service debt because it provides a measure of cash available for such purposes. Management provides an Adjusted EBITDA measure so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company’s performance on a period-over-period basis.

The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company’s operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Amerigon compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.

MORE-MORE-MORE


AMERIGON INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(In thousands, except share data)

 

     September 30,
2011
    December 31,
2010
 
     (unaudited)        
ASSETS     

Current Assets:

    

Cash & cash equivalents

   $ 17,062      $ 26,584   

Short-term investments

     —          9,761   

Accounts receivable, less allowance of $1,800 and $545, respectively

     90,327        18,940   

Inventory

     49,667        6,825   

Derivative financial instruments

     3,177        —     

Assets held for sale

     9,127        —     

Deferred income tax assets

     1,286        4,905   

Prepaid expenses and other assets

     11,153        1,421   
  

 

 

   

 

 

 

Total current assets

     181,799        68,436   

Property and equipment, net

     43,423        4,197   

Goodwill

     24,802        —     

Other intangible assets

     118,288        4,653   

Deferred financing costs

     3,291        —     

Deferred income tax assets

     28,033        1,279   

Other non-current assets

     3,172        857   
  

 

 

   

 

 

 

Total assets

   $ 402,808      $ 79,422   
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current Liabilities:

    

Accounts payable

   $ 48,815      $ 15,275   

Accrued liabilities

     47,809        5,872   

Current maturities of long-term debt

     15,277        —     

Derivative financial instruments

     5,036        —     

Deferred manufacturing agreement – current portion

     —          50   
  

 

 

   

 

 

 

Total current liabilities

     116,937        21,197   

Pension benefit obligation

     3,600        688   

Long-term debt, less current maturities

     66,048        —     

Derivative financial instruments

     18,298        —     

Deferred tax liabilities

     30,685        —     
  

 

 

   

 

 

 

Total liabilities

     235,568        21,885   

Series C Convertible Preferred Stock

     56,589        —     

Shareholders’ equity:

    

Common Stock:

    

No par value; 55,000,000 shares authorized, 23,170,154 and 22,037,466 issued and outstanding at September 30, 2011 and December 31, 2010, respectively

  

 

77,459

  

 

 

65,148

  

Paid-in capital

     23,706        20,128   

Accumulated other comprehensive income (loss)

     (3,429     93   

Accumulated deficit

     (31,899     (27,832
  

 

 

   

 

 

 

Total Amerigon Incorporated shareholders’ equity

     65,837        57,537   

Non-controlling interest

     44,814        —     
  

 

 

   

 

 

 

Total shareholders’ equity

     110,651        57,537   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 402,808      $ 79,422   
  

 

 

   

 

 

 

MORE-MORE-MORE


AMERIGON INCORPORATED

ACQUISITION TRANSACTION EXPENSES, W.E.T. PURCHASE ACCOUNTING IMPACTS

AND OTHER EFFECTS

(In thousands, except per share data)

 

     Current Results     Future Periods (estimated)        
     3 months     9 months     Q4     2012     2013     2014     Thereafter  

Transaction related current expenses

              

Acquisition transaction expenses

     200        5,380        —          —          —          —          —     

Debt retirement expense

     3        970        —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     203        6,350        —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-cash purchase accounting impacts

              

Customer relationships amortization

     2,110        3,165        2,039        8,156        8,156        8,156        50,226   

Technology amortization

     885        1,328        847        3,420        3,420        3,420        9,858   

Product development costs amortization

     446        568        431        2,206        2,258        2,258        1,331   

Order backlog amortization

     1,532        3,063        —          —          —          —          —     

Inventory fair value adjustment

     374        1,497        —          —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     5,347        9,621        3,317        13,782        13,834        13,834        61,415   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Tax effect

     (1,313     (3,189     (768     (3,192     (3,204     (3,204     (14,224

Net Income effect

     4,237        12,782        2,549        10,590        10,630        10,630        47,191   

Non-controlling interest effect

     (975     (1,754     (608     (2,526     (2,535     (2,535     (11,255

Net income available to shareholders effect

     3,262        11,029        1,941        8,064        8,095        8,095        35,936   

Earnings (loss) per share – difference

              

Basic

     0.14        0.49             

Diluted

     0.14        0.48             

Series C Preferred Stock dividend

     2,815        5,738        2,490        6,711        1,622        —          —     

Earnings (loss) per share – difference

              

Basic

     0.12        0.26             

Diluted

     0.12        0.25             

MORE-MORE-MORE


AMERIGON INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

     Nine Months Ended September 30,  
     2011     2010  

Operating Activities:

    

Net income

   $ 1,671      $ 6,222   

Adjustments to reconcile net income to cash provided by operating activities:

    

Depreciation and amortization

     15,454        1,104   

Deferred tax provision

     148        3,440   

Stock option compensation

     1,565        971   

Defined benefit plan expense

     3        188   

Loss from equity investment

     —          22   

Loss on revaluation of financial derivatives

     5,574        —     

Debt retirement expense

     970        —     

Excess tax benefit from equity awards

     (3,044     —     

Changes in operating assets and liabilities:

    

Accounts receivable

     (17,201     (8,931

Inventory

     (5,904     (849

Prepaid expenses and other assets

     (124     (336

Accounts payable

     9,630        6,489   

Accrued liabilities

     (2,107     447   
  

 

 

   

 

 

 

Net cash provided by operating activities

     6,635        8,677   

Investing Activities:

    

Purchases of short-term investments

     —          (8,895

Sales of short-term investments

     —          5,388   

Maturities of short-term investments

     9,761        —     

Purchase of W.E.T. Automotive AG, net of cash acquired

     (113,432     —     

Purchase of ZT Plus assets, net of cash acquired

     —          (1,500

Cash invested in corporate owned life insurance

     —          (266

Purchase of property and equipment

     (3,824     (553

Patent costs

     (921     (617
  

 

 

   

 

 

 

Net cash used in investing activities

     (108,416     (6,443

Financing Activities:

    

Borrowing of debt

     137,083        —     

Repayments of debt

     (105,900     —     

Cash paid for financing costs

     (4,157     —     

Proceeds from the sale of Series C Convertible Preferred Stock

     61,403        —     

Proceeds from the sale of embedded derivatives

     2,610        —     

Excess tax benefit from equity awards

     3,044        —     

Proceeds from sale of W.E.T. Equity to non-controlling interest

     1,175        —     

Stock issued to Series C Preferred Stock Holders

     (121     —     

Proceeds from the exercise of Common Stock options

     1,258        1,256   
  

 

 

   

 

 

 

Net cash provided by financing activities

     96,395        1,256   
  

 

 

   

 

 

 

Foreign currency effect

     (4,136     68   
  

 

 

   

 

 

 

Net (decrease) in cash and cash equivalents

     (9,522     3,558   

Cash and cash equivalents at beginning of period

     26,584        21,677   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 17,062      $ 25,235   
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid for taxes

   $ 3,062      $ 306   
  

 

 

   

 

 

 

Cash paid for interest

   $ 2,322      $ —     
  

 

 

   

 

 

 

Supplemental disclosure of non-cash transactions:

    

Issuance of Common Stock for Series C Preferred Stock redemption

   $ 7,780      $ —     
  

 

 

   

 

 

 

Issuance of Common Stock for Series C Preferred Stock dividend

   $ 2,242      $ —     
  

 

 

   

 

 

 

Issuance of Common Stock under the 2006 Equity Incentive Plan

   $ 666      $ 17   
  

 

 

   

 

 

 

# # # #